Michael Golatta
Overview
Explore the profile of Michael Golatta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cai L, Sidey-Gibbons C, Nees J, Riedel F, Schaefgen B, Togawa R, et al.
J Ultrasound Med
. 2023 Dec;
43(3):467-478.
PMID: 38069582
Objectives: Patients with triple-negative breast cancer (TNBC) exhibit a fast tumor growth rate and poor survival outcomes. In this study, we aimed to develop and compare intelligent algorithms using ultrasound...
12.
Pfob A, Cai L, Schneeweiss A, Rauch G, Thomas B, Schaefgen B, et al.
Ann Surg Oncol
. 2023 Nov;
31(2):957-965.
PMID: 37947974
Background: Breast cancer patients with residual disease after neoadjuvant systemic treatment (NAST) have a worse prognosis compared with those achieving a pathologic complete response (pCR). Earlier identification of these patients...
13.
Marme F, Krieghoff-Henning E, Gerber B, Schmitt M, Zahm D, Bauerschlag D, et al.
Eur J Cancer
. 2023 Oct;
195:113390.
PMID: 37890350
Background: Sentinel lymph node (SLN) status is a clinically important prognostic biomarker in breast cancer and is used to guide therapy, especially for hormone receptor-positive, HER2-negative cases. However, invasive lymph...
14.
15.
Togawa R, Pfob A, Busch C, Fastner S, Gomez C, Goncalo M, et al.
J Ultrasound Med
. 2023 Sep;
43(1):109-114.
PMID: 37772458
Objectives: Shear wave elastography (SWE) is increasingly used in breast cancer diagnostics. However, large, prospective, multicenter data evaluating the reliability of SWE is missing. We evaluated the intra- and interobserver...
16.
Cai L, Sidey-Gibbons C, Nees J, Riedel F, Schafgen B, Togawa R, et al.
Eur Radiol
. 2023 Sep;
34(4):2560-2573.
PMID: 37707548
Objectives: Response assessment to neoadjuvant systemic treatment (NAST) to guide individualized treatment in breast cancer is a clinical research priority. We aimed to develop an intelligent algorithm using multi-modal pretreatment...
17.
Schafgen B, Haller A, Sinn H, Feisst M, Gomez C, Stieber A, et al.
Breast Cancer Res Treat
. 2023 Jun;
201(1):57-66.
PMID: 37302085
Purpose: A previous study in our breast unit showed that the diagnostic accuracy of intraoperative specimen radiography and its potential to reduce second surgeries in a cohort of patients treated...
18.
Rhiem K, Zachariae S, Waha A, Grill S, Hester A, Golatta M, et al.
Breast Care (Basel)
. 2023 Jun;
18(2):106-112.
PMID: 37261134
Introduction: International guidelines recommend genetic testing for women with familial breast cancer at an expected prevalence of pathogenic germline variants (PVs) of at least 10%. In a study sample of...
19.
Forster T, Kohler C, Dorn M, Hafner M, Arians N, Konig L, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
117(4):857-868.
PMID: 37244626
Purpose: The IMRT-MC2 trial was conducted to demonstrate the noninferiority of conventionally fractionated intensity modulated radiation therapy with a simultaneous integrated boost to 3-dimensional conformal radiation therapy with a sequential...
20.
Vogel-Minea C, Bader W, Blohmer J, Duda V, Eichler C, Fallenberg E, et al.
Ultraschall Med
. 2023 Apr;
44(5):520-536.
PMID: 37072031
Alongside mammography, breast ultrasound is an important and well-established method in assessment of breast lesions. With the "Best Practice Guideline", the DEGUM Breast Ultrasound (in German, "Mammasonografie") working group, intends...